Chemoimmunotherapy vs Immunotherapy Monotherapy Receipt in Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Ahluwalia, Vinayak S. [1 ,2 ]
Parikh, Ravi B. [3 ,4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[2] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
[4] Emory Winship Canc Inst, Atlanta, GA USA
来源：
JAMA NETWORK OPEN | 2025年 / 8卷 / 02期
关键词：
D O I：
10.1001/jamanetworkopen.2024.59380
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Emerging Role of Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Mulherkar, Ria
    Grewal, Amardeep S.
    Berman, Abigail T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (04) : 212 - 217
  • [32] Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
    Ge, Xiangwei
    Zhang, Zhibo
    Zhang, Sujie
    Yuan, Fang
    Zhang, Fan
    Yan, Xiang
    Han, Xiao
    Ma, Junxun
    Wang, Lijie
    Tao, Haitao
    Li, Xiaoyan
    Zhi, Xiaoyu
    Huang, Zhiyue
    Hofman, Paul
    Prelaj, Arsela
    Banna, Giuseppe Luigi
    Mutti, Luciano
    Hu, Yi
    Wang, Jinliang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2391 - 2400
  • [33] Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
    Jiang, Juan
    Wang, Yuling
    Gao, Yang
    Sugimura, Haruhiko
    Minervini, Fabrizio
    Uchino, Junji
    Halmos, Balazs
    Yendamuri, Sai
    Velotta, Jeffrey B.
    Li, Min
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 277 - +
  • [34] Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    LANCET, 2021, 397 (10274): : 557 - 559
  • [35] Docetaxel as Second-line Monotherapy for Advanced Non-small Cell Lung Cancer
    Kang, Hyun Mo
    Lee, Jeong Eun
    Jang, Pil Soon
    Lee, Yun Sun
    Kwon, Sun Jung
    An, Jin Young
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 58 (05) : 465 - 472
  • [36] Immunotherapy for Lung Cancer-Improving Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer With Immunotherapy
    Sun, Lova
    Aggarwal, Charu
    CANCER JOURNAL, 2020, 26 (06): : 548 - 554
  • [37] Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non-small cell lung cancer: A network meta-analysis of randomized trials
    Pathak, Ranjan
    De Lima Lopes, Gilberto
    Yu, Han
    Aryal, Madan Raj
    Ji, Wenyan
    Frumento, Katherine Stemmer
    Wallis, Christopher J. D.
    Klaassen, Zachary
    Park, Henry S.
    Goldberg, Sarah B.
    CANCER, 2021, 127 (05) : 709 - 719
  • [38] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [39] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    Current Treatment Options in Oncology, 2021, 22
  • [40] p Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90%
    Shah, Mohsin
    Mamtani, Ronac
    Marmarelis, Melina E.
    Hennessy, Sean
    CLINICAL LUNG CANCER, 2023, 24 (03) : 235 - 243
12345